Next-generation sequencing identifies MicroRNAs that associate with pathogenic autoimmune neuroinflammation in rats

Journal of Immunology

Volumn 190, Issue 8, 2013, Pages 4066-4075

  Bergman, Petra ^a   James, Tojo ^a   Kular, Lara ^a   Ruhrmann, Sabrina ^a   Kramarova, Tatiana ^a   Kvist, Anders ^b   Supic, Gordana ^a   Gillett, Alan ^a   Pivarcsi, Andor ^a   Jagodic, Maja ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; LET 7; MICRORNA; MICRORNA 146A; MICRORNA 181A; MICRORNA 21; MICRORNA 223; PROTEIN PRKCD; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL MIGRATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; LYMPH NODE; MULTIPLE SCLEROSIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INFLAMMATION; MICRORNAS; RATS; RATS, INBRED STRAINS; SEQUENCE ANALYSIS, RNA; SPECIES SPECIFICITY;

EID: 84875994174     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200728     Document Type: Article

References (75)

1. Lee, R. C., R. L. Feinbaum, and V. Ambros. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
2. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
3. Bartel, D. P. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
4. Engels, B. M., and G. Hutvagner. 2006. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 25: 6163-6169.
5. Miranda, K. C., T. Huynh, Y. Tay, Y. S. Ang, W. L. Tam, A. M. Thomson, B. Lim, and I. Rigoutsos. 2006. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126: 1203-1217.
6. Baltimore, D., M. P. Boldin, R. M. O'Connell, D. S. Rao, and K. D. Taganov. 2008. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9: 839-845.
7. Kurowska-Stolarska, M., S. Alivernini, L. E. Ballantine, D. L. Asquith, N. L. Millar, D. S. Gilchrist, J. Reilly, M. Ierna, A. R. Fraser, B. Stolarski, et al. 2011. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc. Natl. Acad. Sci. USA 108: 11193-11198.
8. Pauley, K. M., M. Satoh, A. L. Chan, M. R. Bubb, W. H. Reeves, and E. K. Chan. 2008. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res. Ther. 10: R101.
9. Sonkoly, E., T. Wei, P. C. Janson, A. Sääf, L. Lundeberg, M. Tengvall-Linder, G. Norstedt, H. Alenius, B. Homey, A. Scheynius, et al. 2007. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS ONE 2: e610.
10. Dai, Y., Y. S. Huang, M. Tang, T. Y. Lv, C. X. Hu, Y. H. Tan, Z. M. Xu, and Y. B. Yin. 2007. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16: 939-946.
11. Tang, Y., X. Luo, H. Cui, X. Ni, M. Yuan, Y. Guo, X. Huang, H. Zhou, N. de Vries, P. P. Tak, et al. 2009. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 60: 1065-1075.
12. Junker, A., R. Hohlfeld, and E. Meinl. 2011. The emerging role of microRNAs in multiple sclerosis. Nat Rev Neurol 7: 56-59.
13. Sawcer, S., G. Hellenthal, M. Pirinen, C. C. Spencer, N. A. Patsopoulos, L. Moutsianas, A. Dilthey, Z. Su, C. Freeman, S. E. Hunt, et al; International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2. 2011. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219.
14. Ebers, G. C. 2008. Environmental factors and multiple sclerosis. Lancet Neurol. 7: 268-277.
15. Fenoglio, C., C. Cantoni, M. De Riz, E. Ridolfi, F. Cortini, M. Serpente, C. Villa, C. Comi, F. Monaco, L. Mellesi, et al. 2011. Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis. Neurosci. Lett. 504: 9-12.
16. Otaegui, D., S. E. Baranzini, R. Armañanzas, B. Calvo, M. Muñoz-Culla, P. Khankhanian, I. Inza, J. A. Lozano, T. Castillo-Triviño, A. Asensio, et al. 2009. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS ONE 4: e6309.
17. Martinelli-Boneschi, F., C. Fenoglio, P. Brambilla, M. Sorosina, G. Giacalone, F. Esposito, M. Serpente, C. Cantoni, E. Ridolfi, M. Rodegher, et al. 2012. MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers. Neurosci. Lett. 508: 4-8.
18. Cox, M. B., M. J. Cairns, K. S. Gandhi, A. P. Carroll, S. Moscovis, G. J. Stewart, S. Broadley, R. J. Scott, D. R. Booth, and J. Lechner-Scott; ANZgene Multiple Sclerosis Genetics Consortium. 2010. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS ONE 5: e12132.
19. Keller, A., P. Leidinger, J. Lange, A. Borries, H. Schroers, M. Scheffler, H. P. Lenhof, K. Ruprecht, and E. Meese. 2009. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS ONE 4: e7440.
20. Siegel, S. R., J. Mackenzie, G. Chaplin, N. G. Jablonski, and L. Griffiths. 2012. Circulating microRNAs involved in multiple sclerosis. Mol. Biol. Rep. 39: 6219-6225.
21. Lindberg, R. L., F. Hoffmann, M. Mehling, J. Kuhle, and L. Kappos. 2010. Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. Eur. J. Immunol. 40: 888-898.
22. Sievers, C., M. Meira, F. Hoffmann, P. Fontoura, L. Kappos, and R. L. Lindberg. 2012. Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects. Clin. Immunol. 144: 70-79.
23. De Santis, G., M. Ferracin, A. Biondani, L. Caniatti, M. Rosaria Tola, M. Castellazzi, B. Zagatti, L. Battistini, G. Borsellino, E. Fainardi, et al. 2010. Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J. Neuroimmunol. 226: 165-171.
24. Haghikia, A., A. Haghikia, K. Hellwig, A. Baraniskin, A. Holzmann, B. F. Décard, T. Thum, and R. Gold. 2012. Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study. Neurology 79: 2166-2170.
25. Junker, A., M. Krumbholz, S. Eisele, H. Mohan, F. Augstein, R. Bittner, H. Lassmann, H. Wekerle, R. Hohlfeld, and E. Meinl. 2009. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 132: 3342-3352.
26. Storch, M. K., A. Stefferl, U. Brehm, R. Weissert, E. Wallström, M. Kerschensteiner, T. Olsson, C. Linington, and H. Lassmann. 1998. Autoim-munity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8: 681-694.
27. Du, C., C. Liu, J. Kang, G. Zhao, Z. Ye, S. Huang, Z. Li, Z. Wu, and G. Pei. 2009. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol. 10: 1252-1259.
28. Ponomarev, E. D., T. Veremeyko, N. Barteneva, A. M. Krichevsky, and H. L. Weiner. 2011. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-a-PU.1 pathway. Nat. Med. 17: 64-70.
29. Murugaiyan, G., V. Beynon, A. Mittal, N. Joller, and H. L. Weiner. 2011. Silencing microRNA-155 ameliorates experimental autoimmune encephalomy-elitis. J. Immunol. 187: 2213-2221.
30. Amor, S., N. Groome, C. Linington, M. M. Morris, K. Dornmair, M. V. Gardinier, J. M. Matthieu, and D. Baker. 1994. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153: 4349-4356.
31. Hackenberg, M., M. Sturm, D. Langenberger, J. M. Falcón- Pérez, and A. M. Aransay. 2009. miRanalyzer: a microRNA detection and analysis tool for next-generation sequencing experiments. Nucleic Acids Res. 37(Web Server issue): W68-W76.
32. Hackenberg, M., N. Rodríguez-Ezpeleta, and A. M. Aransay. 2011. miR-analyzer: an update on the detection and analysis of microRNAs in high-throughput sequencing experiments. Nucleic Acids Res. 39(Web Server issue): W132-W138.
33. Kozomara, A., and S. Griffiths-Jones. 2011. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39(Database issue): D152-D157.
34. Schmittgen, T. D., and K. J. Livak. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3: 1101-1108.
35. Gillett, A., K. Maratou, C. Fewings, R. A. Harris, M. Jagodic, T. Aitman, and T. Olsson. 2009. Alternative splicing and transcriptome profiling of experimental autoimmune encephalomyelitis using genome-wide exon arrays. PLoS ONE 4: e7773.
36. de Graaf, K. L., S. Barth, M. M. Herrmann, M. K. Storch, K. H. Wiesmüller, and R. Weissert. 2008. Characterization of the encephalitogenic immune response in a model of multiple sclerosis. Eur. J. Immunol. 38: 299-308.
37. Linsen, S. E., E. de Wit, G. Janssens, S. Heater, L. Chapman, R. K. Parkin, B. Fritz, S. K. Wyman, E. de Bruijn, E. E. Voest, et al. 2009. Limitations and possibilities of small RNA digital gene expression profiling. Nat. Methods 6: 474-476.
38. Martin, G., K. Schouest, P. Kovvuru, and C. Spillane. 2007. Prediction and validation of microRNA targets in animal genomes. J. Biosci. 32: 1049-1052.
39. Ambros, V. 2004. The functions of animal microRNAs. Nature 431: 350-355.
40. Wang, G. K., J. Q. Zhu, J. T. Zhang, Q. Li, Y. Li, J. He, Y. W. Qin, and Q. Jing. 2010. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur. Heart J. 31: 659-666.
41. Mitchell, P. S., R. K. Parkin, E. M. Kroh, B. R. Fritz, S. K. Wyman, E. L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K. C. O'Briant, A. Allen, et al. 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 105: 10513-10518.
42. Alevizos, I., and G. G. Illei. 2010. MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol 6: 391-398.
43. Guan, H., D. Fan, D. Mrelashvili, H. Hao, N. P. Singh, U. P. Singh, P. S. Nagarkatti, and M. Nagarkatti. 2013. MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis. Eur. J. Immunol. 43: 104-114.
44. Waschbisch, A., M. Atiya, R. A. Linker, S. Potapov, S. Schwab, and T. Derfuss. 2011. Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis. PLoS ONE 6: e24604.
45. Thessen Hedreul, M., A. Gillett, T. Olsson, M. Jagodic, and R. A. Harris. 2009. Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis. J. Neuroimmunol. 210: 30-39.
46. Bazzoni, F., M. Rossato, M. Fabbri, D. Gaudiosi, M. Mirolo, L. Mori, N. Tamassia, A. Mantovani, M. A. Cassatella, and M. Locati. 2009. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc. Natl. Acad. Sci. USA 106: 5282-5287.
47. Okuda, Y., S. Sakoda, C. C. Bernard, and T. Yanagihara. 1998. The development of autoimmune encephalomyelitis provoked by myelin oligodendrocyte glyco-protein is associated with an upregulation of both proinflammatory and immu-noregulatory cytokines in the central nervous system. J. Interferon Cytokine Res. 18: 415-421.
48. Hauser, S. L., T. H. Doolittle, R. Lincoln, R. H. Brown, and C. A. Dinarello. 1990. Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40: 1735-1739.
49. Taganov, K. D., M. P. Boldin, K. J. Chang, and D. Baltimore. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103: 12481-12486.
50. Guerau-de-Arellano, M., K. M. Smith, J. Godlewski, Y. Liu, R. Winger, S. E. Lawler, C. C. Whitacre, M. K. Racke, and A. E. Lovett-Racke. 2011. Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity. Brain 134: 3578-3589.
51. Stanczyk, J., C. Ospelt, E. Karouzakis, A. Filer, K. Raza, C. Kolling, R. Gay, C. D. Buckley, P. P. Tak, S. Gay, and D. Kyburz. 2011. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fi-broblast activation. Arthritis Rheum. 63: 373-381.
52. Sethupathy, P., M. Megraw, and A. G. Hatzigeorgiou. 2006. A guide through present computational approaches for the identification of mammalian micro-RNA targets. Nat. Methods 3: 881-886.
53. Guo, H. L., N. T. Ingolia, J. S. Weissman, and D. P. Bartel. 2010. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840.
54. Prat, A., K. Biernacki, J. F. Lavoie, J. Poirier, P. Duquette, and J. P. Antel. 2002. Migration of multiple sclerosis lymphocytes through brain endothelium. Arch. Neurol. 59: 391-397.
55. Denkinger, C. M., M. Denkinger, J. J. Kort, C. Metz, and T. G. Forsthuber. 2003. In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of en-cephalitogenic T cells to the central nervous system. J. Immunol. 170: 1274-1282.
56. Khademi, M., I. Kockum, M. L. Andersson, E. Iacobaeus, L. Brundin, F. Sellebjerg, J. Hillert, F. Piehl, and T. Olsson. 2011. Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course. Mult. Scler. 17: 335-343.
57. O'Connor, R. A., X. Li, S. Blumerman, S. M. Anderton, R. J. Noelle, and D. K. Dalton. 2012. Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system. J. Immunol. 188: 2093-2101.
58. Vaknin-Dembinsky, A., G. Murugaiyan, D. A. Hafler, A. L. Astier, and H. L. Weiner. 2008. Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis. J. Neuroimmunol. 195: 140-145.
59. Schindler, C., D. E. Levy, and T. Decker. 2007. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282: 20059-20063.
60. Frisullo, G., F. Angelucci, M. Caggiula, V. Nociti, R. Iorio, A. K. Patanella, C. Sancricca, M. Mirabella, P. A. Tonali, and A. P. Batocchi. 2006. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J. Neurosci. Res. 84: 1027-1036.
61. Jiang, Z., H. Li, D. C. Fitzgerald, G. X. Zhang, and A. Rostami. 2009. MOG (35-55) i.v suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK/STAT pathways. Eur. J. Immunol. 39: 789-799.
62. Schmied, M., H. Breitschopf, R. Gold, H. Zischler, G. Rothe, H. Wekerle, and H. Lassmann. 1993. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 143: 446-452.
63. Zettl, U. K., E. Mix, J. Zielasek, M. Stangel, H. P. Hartung, and R. Gold. 1997. Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro. Cell. Immunol. 178: 1-8.
64. Zhou, B., S. Wang, C. Mayr, D. P. Bartel, and H. F. Lodish. 2007. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc. Natl. Acad. Sci. USA 104: 7080-7085.
65. Neilson, J. R., G. X. Zheng, C. B. Burge, and P. A. Sharp. 2007. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev. 21: 578-589.
66. Li, Q. J., J. Chau, P. J. Ebert, G. Sylvester, H. Min, G. Liu, R. Braich, M. Manoharan, J. Soutschek, P. Skare, et al. 2007. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161.
67. Goodnow, C. C., J. Sprent, B. Fazekas de St Groth, and C. G. Vinuesa. 2005. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435: 590-597.
68. Sallusto, F., D. Lenig, C. R. Mackay, and A. Lanzavecchia. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187: 875-883.
69. Groom, J. R., J. Richmond, T. T. Murooka, E. W. Sorensen, J. H. Sung, K. Bankert, U. H. von Andrian, J. J. Moon, T. R. Mempel, and A. D. Luster. 2012. CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. Immunity 37: 1091-1103.
70. Kohler, R. E., I. Comerford, S. Townley, S. Haylock-Jacobs, I. Clark-Lewis, and S. R. McColl. 2008. Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis. Brain Pathol. 18: 504-516.
71. Ke, G., L. Liang, J. M. Yang, X. Huang, D. Han, S. Huang, Y. Zhao, R. Zha, X. He, and X. Wu. 2012. MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene. Oncogene. DOI: 10.1038/onc.2012.323.
72. Miyamoto, A., K. Nakayama, H. Imaki, S. Hirose, Y. Jiang, M. Abe, T. Tsukiyama, H. Nagahama, S. Ohno, S. Hatakeyama, and K. I. Nakayama. 2002. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 416: 865-869.
73. Cross, A. H., J. L. Trotter, and J. Lyons. 2001. B cells and antibodies in CNS demyelinating disease. J. Neuroimmunol. 112: 1-14.
74. Hauser, S. L., E. Waubant, D. L. Arnold, T. Vollmer, J. Antel, R. J. Fox, A. Bar-Or, M. Panzara, N. Sarkar, S. Agarwal, et al; HERMES Trial Group. 2008. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358: 676-688.
75. Serrano-Fernández, P., S. Möller, R. Goertsches, H. Fiedler, D. Koczan, H. J. Thiesen, and U. K. Zettl. 2010. Time course transcriptomics of IFNB1b drug therapy in multiple sclerosis. Autoimmunity 43: 172-178.